Valuation: BOIRON

Market Cap 479M 546M 441M 411M 775M 51.89B 791M 5.31B 2.06B 25.47B 2.05B 2B 88.64B P/E 2024
41x
P/E 2025 16.1x
Enterprise Value 431M 491M 397M 370M 698M 46.71B 712M 4.78B 1.85B 22.93B 1.84B 1.8B 79.79B EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
19.96%
Yield 2024
4.48%
Yield 2025 4.46%
1 day-0.36%
1 week-0.72%
Current month-0.36%
1 month-1.78%
3 months-0.36%
6 months-8.91%
Current year-8.91%
1 week 27.5
Extreme 27.5
28.2
1 month 27.1
Extreme 27.1
29
Current year 24.35
Extreme 24.35
30.95
1 year 20.85
Extreme 20.85
32.25
3 years 20.85
Extreme 20.85
56.5
5 years 20.85
Extreme 20.85
56.5
10 years 20.85
Extreme 20.85
92.91
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2025
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Chairman 65 01/07/2011
Director/Board Member 54 10/03/2010
Director/Board Member 51 23/05/2013
Date Insider Type Main position Quantity % Market Cap.
29/10/23Sell

Chairman

4,748 0.0271%
29/10/23Sell 2,978 0.0170%
29/10/23Sell 272,184 1.5513%
Change 5-day change 1-year change 3-year change Capi.($)
-0.36%-0.72%+24.89%-29.59% 549M
+1.27%+0.71%-13.99%-8.59% 12.44B
+0.61%+1.31%-35.65%-59.61% 4.67B
+1.50%+3.86%-10.98%-13.86% 4.29B
+2.33%-1.29%+8.17%-40.25% 3.69B
+2.98%+1.05%+13.17%-14.61% 3.68B
+1.22%-16.35%-14.63%-22.66% 3.01B
+2.80%-1.52%-13.38%-6.27% 2.91B
+3.15%-0.20%-7.61%-26.86% 2.27B
+3.04%+0.91%-11.05%+24.35% 1.61B
Average +1.85%+0.37%-6.11%-19.80% 3.91B
Weighted average by Cap. +1.75%+0.95%-10.57%-19.72%

Financials

2024 2025
Net sales 488M 555M 449M 418M 789M 52.79B 805M 5.4B 2.09B 25.91B 2.09B 2.04B 90.19B 501M 571M 461M 430M 811M 54.26B 827M 5.55B 2.15B 26.63B 2.14B 2.1B 92.7B
Net income 11.34M 12.91M 10.43M 9.72M 18.34M 1.23B 18.71M 125M 48.62M 603M 48.48M 47.43M 2.1B 32.64M 37.18M 30.05M 28M 52.8M 3.53B 53.88M 361M 140M 1.74B 140M 137M 6.04B
Net Debt -49.74M -56.65M -45.78M -42.66M -80.46M -5.39B -82.09M -551M -213M -2.64B -213M -208M -9.2B -47.86M -54.5M -44.05M -41.05M -77.41M -5.18B -78.98M -530M -205M -2.54B -205M -200M -8.85B
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
2,499
Date Price Change Volume
01/07/26 EUR 27.60 -0.36% 772
30/06/26 EUR 27.70 -1.07% 930
29/06/26 EUR 28.00 -0.71% 529
26/06/26 EUR 28.20 +0.71% 994
25/06/26 EUR 28.00 +0.72% 288

Annual profits - Rate of surprise